<--- Back to Details
First PageDocument Content
Nanotechnology / Food and Drug Administration / Research / Clinical research / Nanomaterials / Abbreviated New Drug Application / Animal drugs / Center for Veterinary Medicine / Bioequivalence / Emerging technologies / Pharmacology / Pharmaceutical sciences
Nanotechnology
Food and Drug Administration
Research
Clinical research
Nanomaterials
Abbreviated New Drug Application
Animal drugs
Center for Veterinary Medicine
Bioequivalence
Emerging technologies
Pharmacology
Pharmaceutical sciences

CVM Program Policy and Procedures Manual[removed]

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 147,52 KB

Share Document on Facebook

Similar Documents

Pharmacokinetics / Pharmaceutical industry / Clinical research / Bioequivalence / Generic drug / Bioavailability / Food and Drug Administration / Clinical trial / Pharmaceutical drug / Abbreviated New Drug Application

Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID

DocID: 1ptht - View Document

Food and Drug Administration / Pharmaceuticals policy / Healthcare quality / Prescription Drug User Fee Act / Federal Food / Drug / and Cosmetic Act / Abbreviated New Drug Application / Compounding / United States Code / Controlled Substances Penalties Amendments Act / Industrial Hemp Farming Act

PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296

DocID: 1pnIy - View Document

Food and Drug Administration / Pharmaceutical industry / Pharmaceuticals policy / Food law / Abbreviated New Drug Application / New drug application / Federal Food / Drug / and Cosmetic Act / Generic drug / Approved Drug Products with Therapeutic Equivalence Evaluations / Center for Drug Evaluation and Research / Drug Master File

Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry

DocID: 1p93k - View Document

Health / Food and Drug Administration / Pharmaceutical industry / Pharmacology / Pharmaceuticals policy / Drug safety / New drug application / Abbreviated New Drug Application / Donepezil / Generic drug / Drug Price Competition and Patent Term Restoration Act / Approved Drug Products with Therapeutic Equivalence Evaluations

Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT

DocID: 1m2hg - View Document

Health / Biotechnology / Patent law / Research exemption / Generic drug / Food and Drug Administration / Abbreviated New Drug Application / Drug Price Competition and Patent Term Restoration Act / Declaratory judgment / Approved Drug Products with Therapeutic Equivalence Evaluations / Novartis

Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc

DocID: 1lmCl - View Document